Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in TP53-Aberrant Triple-Negative Breast Cancer.
Hu ZY, Zheng C, Yang J, Ding S, Tian C, Xie N, Xue L, Wu M, Fu S, Rao Z, Price MA, McCarthy JB, Ouyang Q, Lin J, Deng X.
Hu ZY, et al. Among authors: zheng c.
Front Oncol. 2022 Feb 24;12:804466. doi: 10.3389/fonc.2022.804466. eCollection 2022.
Front Oncol. 2022.
PMID: 35280756
Free PMC article.